SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Adeona Pharmaceuticals and Intrexon Corporation Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension